ECT-induced memory impairment. Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
Conditions
Interventions
Intervention 1: In intervention group: 3 Memoral cap/day, since the day before ECT, until two months after last session of ECT. Intervention 2: In control group: 3 placebo cap/day, since the day befor
Treatment - Drugs
Placebo
In intervention group: 3 Memoral cap/day, since the day before ECT, until two months after last session of ECT
In control group: 3 placebo cap/day, since the day before ECT, until two months after the last session of ECT
Sponsors
Behavioural Sciences Research Center of Isfahan University of Medical Sciences
Goldaru pharmaceiutical manufactory
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age range of 15-65; diagnosis of Major Depressive Disorder or Bipolar Disorder; informed acceptance for participating in the study; prescription of at least 4 sessions of ECT by psychiatrist. Exclusion criteria: Dementia or mental retardation; discontinuation of ECT before 4 sessions; refusing cooperation after primary acceptance; delirium during intervention
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Memory. Timepoint: Befor first and fourth ECT session, one and two months after the last session of ECT. Method of measurement: Completion of questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Memoral side effect. Timepoint: Before first and fourth ECT session, one an two months after the last session of ECT. Method of measurement: Questionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Ghafur Mousavi
Behavioural Sciences Research Center of Isfahan University of Medical Sciences
Outcome results
None listed